Apr 17, 2023 7:00am EDT Tonix Pharmaceuticals Announces Two Publications of Data in American Journal of Transplantation Showing TNX-1500 (anti-CD40L mAb) Prolongs Nonhuman Primate Renal and Heart Allograft Survival
Apr 6, 2023 4:15pm EDT Tonix Pharmaceuticals Presents Data from its Vaccine Development Program at the World Vaccine Congress
Apr 5, 2023 7:00am EDT Tonix Pharmaceuticals Announces Poster Presentations at the American Association for Cancer Research Annual Meeting 2023
Mar 30, 2023 7:00am EDT Tonix Pharmaceuticals Presents Positive Efficacy and Safety Data from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 5th International Congress on Controversies in Fibromyalgia
Mar 27, 2023 7:00am EDT Tonix Pharmaceuticals Announces Oral Presentations at the World Vaccine Congress
Mar 23, 2023 4:15pm EDT Tonix Pharmaceuticals Presents Non-Clinical Data on TNX-2900 for the Potential Treatment of Hyperphagia in Adolescents and Young Adults with Prader-Willi Syndrome at the Rare Disease Innovation and Partnership Summit
Mar 23, 2023 7:00am EDT Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia
